Skip to main content

Advertisement

Log in

Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT

  • Interesting Image
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Treglia G, Castaldi P, Rindi G, et al. Diagnostic performance of gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. 2012;42:80–7.

    Article  CAS  PubMed  Google Scholar 

  2. Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part). Ital J Med. 2010;4:84–91.

    Article  Google Scholar 

  3. Rufini V, Baum RP, Castaldi P, et al. Role of PET/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging. 2012;37:1004–20.

    Article  PubMed  Google Scholar 

  4. Oh J-R, Kulkarni H, Carreras C, et al. Ga-68 Somatostatin receptor PET/CT in von Hippel-Lindau disease. Nucl Med Mol Imaging. 2012;46:129–33.

    Article  CAS  Google Scholar 

  5. Treglia G, Salomone E, Petrone G, et al. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Clin Nucl Med. 2013;38:e306–8.

    Article  PubMed  Google Scholar 

  6. Treglia G, Inzani F, Campanini N, et al. A case of insulinoma detected by 68Ga-DOTANOC PET/CT and missed by 18F-dihydroxyphenylalanine PET/CT. Clin Nucl Med. 2013;38:e267–70.

    Article  PubMed  Google Scholar 

  7. Treglia G, Plastino F, Campitiello M. Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT. Endocrine. 2013;43:729–31.

    Article  CAS  PubMed  Google Scholar 

  8. Castaldi P, Rufini V, Treglia G, et al. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med. 2008;113:1056–67.

    Article  CAS  PubMed  Google Scholar 

  9. Treglia G, Farchione A, Stefanelli A, et al. Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors. Pancreas. 2013;42:726–8.

    Article  PubMed  Google Scholar 

  10. Shetty D, Lee Y-S, Jeong JM. 68Ga-labeled radiopharmaceuticals for positron emission tomography. Nucl Med Mol Imaging. 2010;44:233–40.

    Article  CAS  Google Scholar 

  11. Kulkarni HR, Prasad V, Kaemmerer D, et al. High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT. Recent Results Cancer Res. 2013;194:373–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

Giorgio Treglia, Luca Giovanella, Barbara Muoio and Carmelo Caldarella declare that they have no conflicts of interest.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgio Treglia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treglia, G., Giovanella, L., Muoio, B. et al. Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT. Nucl Med Mol Imaging 48, 163–165 (2014). https://doi.org/10.1007/s13139-013-0254-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-013-0254-0

Keywords

Navigation